Table 5.
Multivariable analysis of recurrence-free survival
| n | HR (95% CI) | p-value | |
|---|---|---|---|
| Multivariable analysis of recurrence-free survival | |||
| Tumour subtype | |||
| Luminal A-like | 264 | Ref. | |
| Luminal B-like (HER2−) | 125 | 1.41 (0.86–2.32) | 0.17 |
| Triple negative | 30 | 1.66 (0.76–3.63) | 0.21 |
| HER2-positive | 26 | 1.48 (0.63–3.51) | 0.37 |
| Clinical detectiona | 129 | 1.49 (0.92–2.40) | 0.10 |
| Tumour size (mm) | 1.01 (0.94–1.09) | 0.78 | |
| Age (years) | 0.99 (0.97–1.01) | 0.39 | |
n number of patients with risk factor, HR hazard ratio, Ref. reference, CI confidence interval
aCompared to detection by screening